TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,591
|
11,576
|
11,319 |
| Financial expenses |
7
|
10
|
12 |
| Earnings before taxes |
3,239
|
1,596
|
391 |
| EBITDA |
3,051
|
1,465
|
413 |
| Total assets |
12,127
|
9,628
|
8,612 |
| Current assets |
12,122
|
9,606
|
8,546 |
| Current liabilities |
2,301
|
2,291
|
2,639 |
| Equity capital |
9,523
|
7,206
|
5,930 |
| - share capital |
30
|
31
|
31 |
| Employees (average) |
28
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.5%
|
74.8%
|
68.9% |
| Turnover per employee |
343
|
429
|
419 |
| Profit as a percentage of turnover |
33.8%
|
13.8%
|
3.5% |
| Return on assets (ROA) |
26.8%
|
16.7%
|
4.7% |
| Current ratio |
526.8%
|
419.3%
|
323.8% |
| Return on equity (ROE) |
34.0%
|
22.1%
|
6.6% |
| Change turnover |
-1,591
|
224
|
1,621 |
| Change turnover % |
-14%
|
2%
|
17% |
| Chg. No. of employees |
1
|
0
|
-4 |
| Chg. No. of employees % |
4%
|
0%
|
-13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.